These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32850368)

  • 1. SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer.
    Zhang L; Yuan C; Peng J; Zhou L; Jiang Y; Lin Y; Yin W; Xu S; Ma J; Lu J
    Front Oncol; 2020; 10():1230. PubMed ID: 32850368
    [No Abstract]   [Full Text] [Related]  

  • 2. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHP-2-Induced Activation of c-Myc Is Involved in PDGF-B-Regulated Cell Proliferation and Angiogenesis in RMECs.
    Ma J; Tang W; Gu R; Hu F; Zhang L; Wu J; Xu G
    Front Physiol; 2020; 11():555006. PubMed ID: 33329018
    [No Abstract]   [Full Text] [Related]  

  • 5. Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting.
    Dong Q; Chen H; Li Y; Kong Y; Geng C; Liu Y
    Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):78-83. PubMed ID: 37715420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
    Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
    Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
    Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
    Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
    Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 10. Upregulation Of miR-153 Inhibits Triple-Negative Breast Cancer Progression By Targeting ZEB2-Mediated EMT And Contributes To Better Prognosis.
    Shi D; Li Y; Fan L; Zhao Q; Tan B; Cui G
    Onco Targets Ther; 2019; 12():9611-9625. PubMed ID: 32009797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m
    Lin Y; Jin X; Nie Q; Chen M; Guo W; Chen L; Li Y; Chen X; Zhang W; Chen H; Jiang M; Xiao H; Zhang J; Fu F; Wang C
    Ann Transl Med; 2022 Jan; 10(2):83. PubMed ID: 35282088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1.
    Wang G; Dong Y; Liu H; Ji N; Cao J; Liu A; Tang X; Ren Y
    Oncol Lett; 2019 Oct; 18(4):3837-3844. PubMed ID: 31579087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins.
    Lu H; Wu Z; Wang Y; Zhao D; Zhang B; Hong M
    Phytomedicine; 2022 Sep; 104():154291. PubMed ID: 35839735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micro ribonucleic acid-448 regulates zinc finger e-box binding homeobox 1 to inhibit the growth of breast cancer cells and increase their sensitivity to chemotherapy.
    Zhou Y; Sun L; Zhang Y; Chen K
    Clinics (Sao Paulo); 2022; 77():100089. PubMed ID: 35905576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC.
    Xie H; Yan T; Lu X; Du Y; Xu S; Kong Y; Yu L; Sun J; Zhou L; Ma J
    Front Immunol; 2022; 13():1033367. PubMed ID: 36275705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOTCH3 inhibits transcription factor ZEB1 expression and metastasis of breast cancer cells via transcriptionally upregulating miR-223.
    Chen WJ; Zhong HT; Wu HT; Hou YY; Wu Z; Fang ZX; Liu J
    J Cancer; 2024; 15(1):192-203. PubMed ID: 38164285
    [No Abstract]   [Full Text] [Related]  

  • 17. miRNA-641 inhibits the proliferation, migration, and invasion and induces apoptosis of cervical cancer cells by directly targeting
    Yao R; Zheng H; Wu L; Cai P
    Onco Targets Ther; 2018; 11():8965-8976. PubMed ID: 30588009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-508 is downregulated in clear cell renal cell carcinoma and targets ZEB1 to suppress cell proliferation and invasion.
    Wang W; Hu W; Wang Y; Yang J; Yue Z
    Exp Ther Med; 2019 May; 17(5):3814-3822. PubMed ID: 30988768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.
    Kong D; Li Y; Wang Z; Banerjee S; Ahmad A; Kim HR; Sarkar FH
    Stem Cells; 2009 Aug; 27(8):1712-21. PubMed ID: 19544444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
    Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z
    BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.